Science & research

Follow the evidence.

Research, publications and scientific context behind the Genimen story.

Genimen's product story is built around a kiwi-derived ingredient with a published research history. This section presents that evidence with context, citations and clear distinctions between ingredient-level research and finished-product evidence.

Our approach

Nature gives us the starting point. Research gives us the framework.

We look for natural ingredients with meaningful research, then translate that knowledge into practical nutraceutical formulations. Our aim is to make scientific information clearer and more useful for the people who rely on it.

Published work

Research library

Explore the published work associated with kiwifruit and kiwi fruit extract. Each entry names what was actually studied.

Studied: Kiwifruit extract

Inhibitory effects of kiwifruit extract on human platelet aggregation and plasma angiotensin-converting enzyme activity

Dizdarevic LL, Biswas D, Uddin MM, Jørgenesen A, Falch E, Bastani NE, Duttaroy AK

Platelets. 2014;25(8):567–575

Research examining the effects of kiwifruit extract on platelet aggregation and ACE activity.

DOI 10.3109/09537104.2013.852658

Studied: Whole kiwifruit

Kiwifruit decreases blood pressure and whole-blood platelet aggregation in male smokers

Karlsen A, Svendsen M, Seljeflot I, Laake P, Duttaroy AK, Drevon CA, Arnesen H, Tonstad S, Blomhoff R

Journal of Human Hypertension. 2013;27:126–130 · Oslo antioxidant study, NCT00520819

A human study examining blood pressure and whole-blood platelet aggregation in male smokers following a kiwifruit intervention.

DOI 10.1038/jhh.2011.116

Studied: Kiwifruit (review)

Cardioprotective Properties of Kiwifruit

Duttaroy AK

Advances in Food and Nutrition Research. Vol. 68, 2013, pp. 273–282

Scientific review covering the cardiovascular properties of kiwifruit.

DOI 10.1016/B978-0-12-394294-4.00015-8

Studied: Antioxidant-rich diets

Compliance, tolerability and safety of two antioxidant-rich diets: a randomised controlled trial in male smokers

Karlsen A, Svendsen M, Seljeflot I, Sommernes MA, Sexton J, Brevik A, et al.

British Journal of Nutrition. 2011;106(4):557–571

Randomized controlled research examining compliance, tolerability and safety of antioxidant-rich diets.

PubMed 21806852

The patent record

The kiwifruit research sits behind a granted patent family. These are the documents as supplied — read the proprietor and inventor lines rather than any summary of them.

European patent specification EP 2 648 741 B1
EP 2 648 741 B1 — “Cardio-protective agents from kiwifruit”. Proprietor: University of Oslo. Inventor: A. K. Duttaroy. View the official record ↗
United States patent application publication US 2014/0314989 A1
US 2014/0314989 A1 — “Cardio-protective agents from kiwifruit”, application publication. Inventor: Asim Kanti Duttaroy. View the official record ↗

Research deserves context.

Each entry identifies the ingredient or intervention studied, the study design, participants, publication and outcome. Research on whole kiwifruit or kiwi fruit extract is not presented as a clinical trial of Genactin Plus.

One cited human study examined 102 male smokers, ages 44–74, in an 8-week intervention with 3 kiwifruit per day, reporting changes in blood pressure, whole-blood platelet aggregation and ACE activity. These are the findings of that study on whole kiwifruit — not guaranteed outcomes of any Genimen product.

From evidence to formulation.

See how the ingredient behind this research is used across the Genimen product family.

Discover Genactin® Explore products Ask an Expert